Moreover, TGF-beta1 may amplify Aβ (1-42) (accumulation of the Aβ peptide in the brain is a crucial factor in the development of AD)-mediated neurodegeneration in AD through SMAD7 and beta-catenin interaction and nuclear localization. This evidence concerns the gene SMAD7 and Alzheimer disease.